Abstract:Qianyu Zhang, 1, * Tong Wang, 1, * Jiawei Jin, 1, 2 Xiaoqian Shi, 2 Aiben Huang, 3 Zhenru Ma, 1 Jiujie Li, 4 Shiyu Wang, 4 Runlin Z. Ma, 4, 5 Qiuhong Fang 1 1 Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, People's Republic of China; 2 The Clinical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, People's Republic of China; 3 Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, People's Republic of China; 4 School of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China; 5 State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, People's Republic of China *These authors contributed equally to this work Correspondence: Qiuhong Fang Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang South Road, Chaoyang District, Beijing 100020, People's Republic of China Tel +86 10-85231451 Fax +86 10-85231412 Email fangmaster123@163.com Runlin Z. Ma Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, S2-316 Building #2, West Beichen Road, Chaoyang District, Beijing 100101, People's Republic of China Tel +86 10-64806599 Fax +86 10-64806598 Email rlma@genetics.ac.cn Background: Chronic obstructive pulmonary disease (COPD), characterized by irreversible airflow limitation, is a highly prevalent lung disease worldwide and imposes increasing disease burdens globally. Emphysema is one of the primary pathological features contributing to the irreversible decline of pulmonary function in COPD patients, but the pathogenetic mechanisms remain unclear. Reticulocalbin 3 (Rcn3) is an endoplasmic reticulum (ER) lumen protein localized in the secretory pathway of living cells. Rcn3 in type II alveolar epithelial cell (AECIIs) has been reported to play a critical role in regulating perinatal lung development and bleomycin-induced lung injury-repair processes. We hypothesized that Rcn3 deficiency is associated with the development of emphysema during COPD, which is associated with the dysfunction of injury-repair modulated by alveolar epithelial cells. Materials and Methods: We examined Rcn3 expression in lung specimens from COPD patients and non-COPD control patients undergoing lung lobectomy or pneumonectomy. Two mouse models of emphysema were established by cigarette smoke (CS) exposure and intratracheal instillation of porcine pancreatic elastase (PPE). Rcn3 expression was detected in the lung tissues from these mice. Furthermore, conditional knockout (CKO) mice with Rcn3 deletion specific to AECIIs were used to explore the role of Rcn3 in PPE-induced emphysema progression. Rcn3 protein expression in lung tissues was evaluated by Western blot and immunohistochemistry. Rcn3 mRNA expression in lung tissues was detected by qPCR. Results: Rcn3 expression was significantly increased in the lung specimens from COPD patients versus non-COPD patients and the level of Rcn3 increase was associated with the degree of emphysema. Rcn3 expression were also significantly up-regulated in both CS-induced and PPE-induced emphysematous mouse lungs. Moreover, the selective ablation of Rcn3 in AECIIs significantly alleviated severity of the mouse emphysema in response to intratracheal installation of PPE. Conclusion: Our data, for the first time, indicated that suppression of Rcn3 expression in AECIIs has a beneficial effect on PPE-induced emphysema. Keywords: COPD, emphysema, Rcn3, type II alveolar epithelial cell

NCR negative group 3 innate lymphoid cell (NCR- ILC3) participates in abnormal pathology of lung in cigarette smoking-induced COPD mice

Dendritic Cells Promote the Differentiation of ILCs into NCR-ILC3s in the Lungs of Mice Exposed to Cigarette Smoke

Association of NLRP3 inflammasome signaling pathway with progression of chronic obstructive pulmonary disease

Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway

WNT/β-catenin Signaling Regulates Cigarette Smoke-Induced Airway Inflammation Via the PPARδ/p38 Pathway

Cigarette Smoke-Induced Lymphoid Neogenesis in COPD Involves IL-17/RANKL Pathway

Imbalance of Th17/Treg Cells in Mice with Chronic Cigarette Smoke Exposure.

Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice

Cigarette smoke with IL-33 delivery leads to an exacerbated phenotype and hallmarks of mixed type 1/type 2 lung inflammation in mice

Blocking IL‐23 Signaling Mitigates Cigarette Smoke‐Induced Murine Emphysema

Activating Transcription Factor 3 Represses Cigarette Smoke-Induced IL6 and IL8 Expression Via Suppressing NF-κB Activation.

Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking

Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model

Upregulation of IL-17A/F from Human Lung Tissue Explants with Cigarette Smoke Exposure: Implications for COPD

Downregulation of miRNA promotes Tc17 differentiation and emphysema via de-repression of RORγt

To investigate the role of Th17 cell in lung tissue of tobacco smoke correlated COPD patients

Anti-Interleukin-17 Antibodies Attenuate Airway Inflammation in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease in Mice

IL-33 induced inflammation exacerbated the development of chronic obstructive pulmonary disease through oxidative stress

TLR and NKG2D signaling pathways mediate CS-induced pulmonary pathologies

Increased IFN-γ-producing Th17/Th1 cells and their association with lung function and current smoking status in patients with chronic obstructive pulmonary disease

NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease